Fractyl’s patent portfolio
Fractyl’s products are protected by patents in the U.S. and elsewhere.
The Revita® System, either alone or in combinations with its accessories, kits, and procedures, may be protected by one or more of the following patents:
|Patent Number||Issue Date||Title|
|11,311,333||April 26, 2022||Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract|
|11,246,639||February 15, 2022||Methods, Systems and Devices for Performing Multiple Treatments on a Patient|
|11,185,367||Nov. 30, 2021||Methods and systems for treating diabetes and related diseases and disorders|
|11,166,761||Nov. 9, 2021||Injectate Delivery Devices, Systems, and Methods|
|10,959,774||April 13, 2021||Injectate Delivery Devices, Systems and Methods|
|10,869,718||March 30, 2021||Methods and Systems for Treating Diabetes and Related Diseases and Disorders|
|10,765,474||December 15, 2020||Injectate Delivery Devices, Systems and Methods|
|10,610,663||September 8, 2020||Systems, Devices and Methods for Performing Medical Procedures in the Intestine|
|10,349,998||July 16, 2019||Heat Ablation Systems, Devices and Methods for the Treatment of Tissue|
|9.757,535||September 12, 2017||Systems, Devices, and Methods for Performing Medical Procedures in the Intestine|
|9.844.641||December 19, 2017||Systems, Devices, and Methods for Performing Medical Procedures in the Intestine|
Additional patents may be issued and pending in the U.S. and elsewhere.